Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1076623 | 0.78 | IDUA (0.31) | IDUASUCNR1 | |
| SCHEMBL8097480 | 0.76 | IDUA (0.30) | IDUA | |
| SCHEMBL16750226 | 0.76 | SUCNR1 (0.35) | IDUASUCNR1 | |
| SCHEMBL29740164 | 0.75 | IDUA (0.33) | IDUASUCNR1 | |
| SCHEMBL13858344 | 0.75 | IDUA (0.33) | IDUASUCNR1 | |
| SCHEMBL25910365 | 0.72 | — | — | |
| SCHEMBL26727149 | 0.72 | — | — | |
| SCHEMBL21097605 | 0.70 | APLNR (0.33) | IDUASUCNR1 | |
| SCHEMBL31028169 | 0.70 | SUCNR1 (0.36) | IDUASUCNR1 | |
| SCHEMBL23247975 | 0.68 | IDUA (0.38) | IDUASUCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10966447-B2 | Glucosyringic acid analogs as sweetness profile modifiers | PEPSICO, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20180020708-A1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | PEPSICO, INC. | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10966447-B2 | Glucosyringic acid analogs as sweetness profile modifiers | GPR119, TAS2R42, TAS2R31 | IDUA 343/4885SUCNR1 53/4885 |
| US-20180020708-A1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | GPR119, TAS2R42, TAS2R31 | IDUA 343/4885SUCNR1 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.